About Genechem
Genechem is a Healthcare company based in Shanghai (China) founded in 2002. Molecular biology products and services are developed by Genechem. Genechem has raised $56.35 million across 2 funding rounds from investors including Humanwell Healthcare, Chuangyuan InnoSpring and Free Trade Zone Fund. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Genomics. Its competitors include Novogene Corporation and Beikang Medical; 2 of its 2 listed competitors have raised funding.
Company details
Genechem was established in 2002 in Shanghai, China, within the biotechnology sector focused on molecular biology. A range of gene delivery tools is produced, including lentiviral vectors for knockdown and overexpression, adenoviral systems, adeno-associated viral constructs, and plasmid libraries such as shRNA-SET and CRISPR-Pool. Genomics services are provided alongside custom animal model development for research applications.
- Headquarters Shanghai, China
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genechem.com.cn
- Total Equity Funding$56.35M (USD)
in 2 rounds
- Latest Funding Round$56.35M (USD), Series C
Apr 2020
- InvestorsHumanwell Healthcare
& 3 more
Funding Insights of Genechem
Genechem has successfully raised a total of $56.35M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $56.35 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $56.35M
- Total Rounds 2
- Last Round Series C — $56.35M
- Investors Count 4
All 2 funding rounds of Genechem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $56.35M | Series C | – | Free Trade Zone Fund | |
| Mar 2019 | Series A | – | Humanwell Healthcare | – |
4 investors in total: 4 institutional.
Investors in Genechem
Genechem has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Humanwell Healthcare, Chuangyuan InnoSpring and Free Trade Zone Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity & venture capital firm | ftzfund.com.cn | Shanghai, China | ||
Principle Capital is engaged in strategic investments and equity partnerships. | 2011 | principle-capital.com | Shanghai, China | |
Laboratory and blood bank equipment are manufactured for clinical use. | 2012 | innospring.com | Shanghai, China | |
Provider of pharmaceutical products and services | 1993 | humanwell.com.cn | Wuhan, China |
Investor details for Genechem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genechem
3 dated milestones of Genechem across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Genechem is founded.
- Funding First funding round.
- Funding Latest funding round, Series C, of $56.4M.
Competitors of Genechem
Genechem has 2 listed competitors in our database, 2 of them funded. They include Novogene Corporation and Beikang Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | NGS-based diagnostic solutions for neonatal screening are developed. |
Detailed competitors of Genechem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genechem
The website of Genechem (genechem.com.cn) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 11.3% vs previous month
Websites whose visitors overlap most with Genechem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hanbio.net | 100% | #9,012,140 | View details | ||
| genepharma.com | 91% | #11,292,195 | View details | ||
| knowgene.com | 87% | View details | |||
| oebiotech.com | 87% | 14.5K | #1,065,951 | View details | |
origene.com.cn | origene.com.cn | 82% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Genechem
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genechem
Complete news archive for Genechem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genechem
Genechem was founded in 2002 and raised its 1st funding round 17 years after it was founded.
Genechem is headquartered in Shanghai, China.
Genechem is a funded company, having raised a total of $56.35M across 2 funding rounds to date.
Genechem was established in 2002 in Shanghai, China, within the biotechnology sector focused on molecular biology. A range of gene delivery tools is produced, including lentiviral vectors for knockdown and overexpression, adenoviral systems, adeno-associated viral constructs, and plasmid libraries such as shRNA-SET and CRISPR-Pool. Genomics services are provided alongside custom animal model development for research applications.
Genechem's top competitors include Novogene Corporation and Beikang Medical.
Genechem has 4 investors. Key investors include Humanwell Healthcare, Chuangyuan InnoSpring, Free Trade Zone Fund, and Principle Capital.